Patent ID: 7951847

Claim:
A method of increasing a human HIV patient's CD4 + cell count, comprising: administering to the patient, during a treatment period, a nutrient composition and at least one anti-retroviral drug; the nutrient composition comprising, in per patient kg body weight per day: 1.43 mg to 11.42 mg alpha lipoic acid; 3.57 mg to 28.58 mg acetyl L-carnitine; 4.28 mg to 34.28 mg N-acetyl-cysteine; 0.10 mg to 0.86 mg zinc; 0.71 micrograms to 5.72 micrograms selenium; 2.14 mg to 17.14 mg vitamin C; 1.07 mg to 8.58 mg bioflavinoid complex; and 2.85 IU to 22.86 IU vitamin E; one or more antioxidants selected from the group consisting of co-enzyme Q10 and glutathione; and one or more vitamins or minerals selected from the group consisting of beta-carotene, vitamin A, vitamin B1, vitamin B2, vitamin B6, niacinamide, calcium panthothenate, folic acid, vitamin B12, copper, manganese, chromium, and molybdenum; whereby the patient's CD4+ cell count is increased by at least 25% during the treatment period.